Awarded
Część 1. Koncentrat czynnika krzepnięcia IX (osoczopochodnego lub rekombinowanego)
Track this recordFree account — get alerted when a contract here runs out.
- Winners
- Octapharma AG
- Contract value
- PLN 4,320,000
- Published
- 23 Apr 2025
- Awarded
- 22 Apr 2025
- Contract start
- 22 Apr 2025
- Contract end
- 23 Apr 2026estimated
- Region
- Extra-Regio NUTS 3